Trial · NCT00289783
Results by group426
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 426
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Anti-Polyribosyl Ribitol Phosphate (PRP) Antibody Concentrations | Menhibrix A Group | 10.170 | 95% Confidence Interval 8.855 to 11.681 | microgram per milliliter (µg/mL) | |
| Anti-Polyribosyl Ribitol Phosphate (PRP) Antibody Concentrations | Menhibrix B Group | 11.424 | 95% Confidence Interval 9.710 to 13.441 | microgram per milliliter (µg/mL) | |
| Anti-Polyribosyl Ribitol Phosphate (PRP) Antibody Concentrations | Menhibrix C Group | 11.438 | 95% Confidence Interval 9.503 to 13.768 | microgram per milliliter (µg/mL) | |
| Anti-Polyribosyl Ribitol Phosphate (PRP) Antibody Concentrations | Menhibrix Group | 11.021 | 95% Confidence Interval 10.027 to 12.114 | microgram per milliliter (µg/mL) | |
| Anti-Polyribosyl Ribitol Phosphate (PRP) Antibody Concentrations | ActHIB Group | 6.463 | 95% Confidence Interval 5.288 to 7.900 | microgram per milliliter (µg/mL) | |
| Neisseria Meningitidis Serogroup C (MenC) Serum Bactericidal Assay Using Human Complement (hSBA) Antibody Titers | Menhibrix A Group | 910.0 | 95% Confidence Interval 754.6 to 1097.3 | Titers | |
| Neisseria Meningitidis Serogroup C (MenC) Serum Bactericidal Assay Using Human Complement (hSBA) Antibody Titers | Menhibrix B Group | 1118.0 | 95% Confidence Interval 931.1 to 1342.5 | Titers | |
| Neisseria Meningitidis Serogroup C (MenC) Serum Bactericidal Assay Using Human Complement (hSBA) Antibody Titers | Menhibrix C Group | 885.7 | 95% Confidence Interval 712.4 to 1101.2 | Titers | |
| Neisseria Meningitidis Serogroup C (MenC) Serum Bactericidal Assay Using Human Complement (hSBA) Antibody Titers | Menhibrix Group | 967.6 | 95% Confidence Interval 864.0 to 1083.5 | Titers | |
| Neisseria Meningitidis Serogroup C (MenC) Serum Bactericidal Assay Using Human Complement (hSBA) Antibody Titers | ActHIB Group | 2.5 | 95% Confidence Interval 2.2 to 2.9 | Titers | |
| Neisseria Meningitidis Serogroup Y (MenY) Serum Bactericidal Assay Using Human Complement (hSBA) Antibody Titers | Menhibrix A Group | 178.9 | 95% Confidence Interval 136.4 to 234.6 | Titers | |
| Neisseria Meningitidis Serogroup Y (MenY) Serum Bactericidal Assay Using Human Complement (hSBA) Antibody Titers | Menhibrix B Group | 288.1 | 95% Confidence Interval 232.8 to 356.6 | Titers | |
| Neisseria Meningitidis Serogroup Y (MenY) Serum Bactericidal Assay Using Human Complement (hSBA) Antibody Titers | Menhibrix C Group | 249.6 | 95% Confidence Interval 195.6 to 318.7 | Titers | |
| Neisseria Meningitidis Serogroup Y (MenY) Serum Bactericidal Assay Using Human Complement (hSBA) Antibody Titers | Menhibrix Group | 236.6 | 95% Confidence Interval 205.7 to 272.1 | Titers | |
| Neisseria Meningitidis Serogroup Y (MenY) Serum Bactericidal Assay Using Human Complement (hSBA) Antibody Titers | ActHIB Group | 2.2 | 95% Confidence Interval 2.0 to 2.4 | Titers | |
| hSBA-MenC Antibody Titers | Menhibrix Group | hSBA-MenC [post-dose 4] | 2039.8 | 95% Confidence Interval 1746.3 to 2382.6 | Titers |
| hSBA-MenC Antibody Titers | ActHIB Group | hSBA-MenC [post-dose 4] | 4.3 | 95% Confidence Interval 3.2 to 5.8 | Titers |
| hSBA-MenC Antibody Titers | Menhibrix Group | hSBA-MenC [pre-dose 4] | 180.3 | 95% Confidence Interval 155.6 to 208.8 | Titers |
| hSBA-MenC Antibody Titers | ActHIB Group | hSBA-MenC [pre-dose 4] | 3.0 | 95% Confidence Interval 2.4 to 3.7 | Titers |
| hSBA-MenY Antibody Titers | Menhibrix Group | hSBA-MenY [post-dose 4] | 1389.5 | 95% Confidence Interval 1205.0 to 1602.2 | Titers |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00289783/results